Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 26, 2014 - Issue 2
258
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Wollastonite toxicity: an update

, , , , &
Pages 95-112 | Received 28 Aug 2013, Accepted 16 Oct 2013, Published online: 04 Feb 2014

References

  • Addison J, McConnell EE. (2008). A review of the carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles. Reg Toxicol Pharm 52:S187–99
  • Adlung-Baykara M. (2000). The isolation of wollastonite crystals in clay ceramic bodies. Qualicer, 115--19. [Online] Available at: http://www.qualicer.org/recopilatorio/ponencias/pdf/0032300e.pdf. [Last accessed: 18 Nov 2013]
  • Agency for Toxic Substances and Disease Registry (ATSDR). (2004). Toxicological profile for synthetic vitreous fibers. September 2004. Atlanta, Georgia. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp161.pdf. [Last accessed: 18 Nov 2013]
  • Aminozarbian M-G, Barati M, Salehi I, Musavi SV. (2012). Biocompatibility of mineral trioxide aggregate and three new endodontic cements: an animal study. Dent Res J 9:54–9
  • Asar NV, Korkmaz T, Gul EB. (2010). The effect of wollastonite incorporation on the linear firing shrinkage and flexural strength of dental aluminous core ceramics: a preliminary study. Mater Design 31:2540–5
  • Aslam M, Ashquin M, Rahman Q. (1992). In vitro cytotoxic effects of wollastonites on rat hepatocytes: II. Lipid peroxidation and glutathione depletion. Bull Environ Contam Toxicol 49:547–54
  • Aslam M, Arif MJ, Rahman Q. (1995). Red blood cell damage by wollastonite, in vitro study. J Appl Toxicol 15:27–31
  • Bauer RR, Copeland JR, Santini K. (1994). Wollastonite. In: Carr DD. (eds.) Industrial minerals and rocks, 6th edition. Littleton, CO: Society for Mining, Metallurgy, and Exploration, Inc, 1119–28
  • Bellmann B, Muhle H. (1994a). Investigation of the biodurability of wollastonite and xonotlite. Environ Health Persp 102:191–5
  • Bellmann B, Muhle H, (1994b). Untersuchungen zur Biobeständigkeit von Wollastonitfasern. Zbl Arbeitsmed 44:118–23
  • Bender JR, Hadley JG. (1994). Glass fiber manufacturing and fiber safety: the producer’s perspective. Environ Health Perspect 102:37–40
  • Beno M, Hurbánková M, Dusinska M, et al. (2005). Multinucleate cells (MNC) as sensitive semiquantitative biomarkers of the toxic effect after experimental fibrous dust and cigarette smoke inhalation by rats. Exp Toxicol Pathol 57:77–87
  • Bernstein DM, Chevalier J, Smith P. (2003). Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure. Inhal Toxicol 15:1387–419
  • Blake DJ, Bolin CM, Cox DP, et al. (2007). Internalization of Libby amphibole asbestos and induction of oxidative stress in murine macrophages. Toxicol Sci 99:277–88
  • Bozadzhiev LS, Bozadzhiev RL. (2004). Synthetic wollastonite from diatomite and carbonate waste. Qualicer, 63--5. [Online] Available at: www.qualicer.org/recopilatorio/ponencias/pdf/0432130e.pdf. [Last accessed: 18 Nov 2013]
  • Broaddus C, Yang C, Scavo LM, et al. (1996). Asbestos induces apoptosis of human and rabbit-pleural mesothelial cells via reactive oxygen species. J Clin Invest 98:2050–9
  • Brooks A, Rozenwalk MN, Geohrig LD, Lio LW, Steenhuis T. (2000). Phosphorus removal by wollastonite: a constructed wetland substrate. Ecol Eng 15:121–32
  • Cambelová M, Juck A. (1994). Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz. Occup Environ Med 51:343–6
  • Canadian Wollastonite. (2008). Emerging applications of wollastonite. CanadianWollastonite.com. [Online] Available at: www.canadianwollastonite.com/EmergingApplications.htm. [Last accessed: 18 Nov 2013]
  • Carbonari D, Campopiano A, Ramires D, et al. (2011). Angiogenic effect induced by mineral fibres. Toxicology 288:34–42
  • Carrodeguas RG, De Aza AH, De Aza PN, et al. (2007). Assessment of natural and synthetic wollastonite as source for bioceramics preparation. J Biomed Mater Res 83:484–95
  • Černá S, Beňo M, Hurbánková M, et al. (2004). Evaluation of bronchoalveolar lavage fluid cytotoxic parameters after inhalation exposure to amosite and wollastonite fibrous dusts combined with cigarette smoke. Cent Eur J Publ Health 12:S20–3
  • Chang HS, Kim KA, Kim EK, et al. (1999). The toxicologic effect of TAFMAG on RAW 264.7 cell. Korean J Occup Environ Med 11:340–9
  • Collan Y, Kosma VM, Anttonen H, Kulju T. (1986). Toxicity of richterite in hemolysis test and macrophage cultures. Arch Toxicol Suppl 9:292–5
  • Crooks AF. (1999). Wollastonite in South Australia. Department of Primary Industries and Resources South Australia. Report Book 99/00016, August, 1999, 16 pp
  • Davis JMG. (1994). The role of clearance and dissolution in determining the durability or biopersistence of mineral fibers. Environ Health Perspect 102:113–17
  • Datnoff LE, Rodrigues FA. (2005). The role of silicon in suppressing rice diseases. APSnet feature story. St. Paul, Minnesota: American Phytopathological Society, 28 pp
  • Deng JJ, Dong FQ, Wang LM, et al. (2011). Comparative study of the cytotoxicity induced by chrysotile asbestos, rock wool, and substitute fibers in vitro. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 29:535–7. [in Chinese]
  • Dong F, Deng J, Wu F, et al. (2006). An in vitro investigation of pulmonary alveolar macrophage cytotoxicity introduced by fibrous and grainy mineral dusts. Acta Geol Sinica Engl Ed 80:589–95
  • Douglas D. (2001). Chrysotile asbestos: health assessment of alternative materials in the event of a phase out of uses of chrysotile asbestos in Australia. Report prepared for the National Occupational Health and Safety Commission, Sydney, Australia, 93 pp
  • Eastes W, Hadley JG. (1996). A mathematical model of fiber carcinogenicity and fibrosis in inhalation and intraperitoneal experiments in rats. Inhal Toxicol 8:323–43
  • Fattah H. (1994). Wollastonite – new aspects promise growth. Ind Miner 326:21–43
  • Finkelstein MM, Dufresne A. (1999). Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med 35:401–12
  • Fujita H, Iida H, Ido K, et al. (2000). Porous apatite-wollastonite glass-ceramic as an intramedullary plug. J Bone Joint Surg 82:B614–18
  • Georgiadis P. (2003). Oxidative stress and genotoxicity by mineral fibers: in vitro studies. Paper presented at From Hazard to Risk, European Environmental Mutagen Society 33rd annual meeting, organized by the UK Environmental Mutagen Society, August 24–28, 2003, Aberdeen Exhibition and Conference Centre, Aberdeen, Scotland, UK. [Online] Available at: http://www.swan.ac.uk/cget/ejgt/EEMS03.pdf. [Last accessed: 18 Nov 2013]
  • Gladun VD, Khol’kin AI, Akat’eva LV. (2007). Prospects for production of synthetic wollastonite in Russia. Theor Found Chem Eng 41:303–609
  • Governa M, Camilucci L, Amati M, et al. (1998). Wollastonite fibers in vitro generate reactive oxygen species able to lyse erythrocytes and activate the complement alternate pathway. Toxicol Sci 44:32–8
  • Hamilton RF, Li L, Rashi I, Holian A. (1996). Asbestos induces apoptosis in human alveolar macrophages. APS Manuscript Number L368-5, APStracts 3:0113L. [Online] Available at: www.uth/tmc.edu/apstracts/1996/lung/July/1131.html. [Last accessed: 18 Nov 2013]
  • Hamilton RF, Pfau JC, Marshall GD, Holian A. (2001). Silica and PM1648 modify human alveolar macrophage antigen-presenting cell activity in vitro. J Environ Pathol Toxicol Oncol 20:75–84
  • Haner S, Çuhadaroğlu D. (2013). Wollastonite: a review. Jeoloji Muhendisligi Dergisi 37:63–82. [in Turkish]
  • Hanke W, Sepulveda MJ. (1983). Health Hazard Evaluation Determination Report. Willsboro, NY: NYCO (MHETA 81-112); Cincinnati, OH: NIOSH
  • Hanke W, Sepulveda MJ, Watson A, Jankovic J. (1984). Respiratory morbidity in wollastonite workers. Br J Ind Med 4:474–9
  • Hard GC, Betz LJ, Seely JC. (2012). Association of advanced chronic progressive nephropathy (CPN) with renal tubule tumors and precursor hyperplasia in control F344 rats from two-year carcinogenicity studies. Toxicol Path 40:473–81
  • Hattori H, Matsuoka H, Yamamoto K. (2010). Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study. J Orthop Surg 18:63–7
  • Haynes RC. (2010). A worn-out welcome: renewed call for a global ban on asbestos. Environ Health Perspect 118:A298–303
  • Hedenborg M, Klockars M. (1987). Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear. J Clin Pathol 40:1189–93
  • Hellingwerf R. (2011). Desk study on wollastonite: occurrence, market, concentration and beneficiation. HGRAB Report no. 2011-05-12. [Online] Available at: http://www.empireminingcorp.com/i/pdf/techrep-2011-09-01-hgrab-wollastonite.pdf [Last accessed: 18 Nov 2013]
  • Hesterberg TW, Chase G, Axten C, et al. (1998). Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharm 151:262–75
  • Hesterberg TW, Hart GA. (2001). Synthetic vitreous fibers: a review of toxicology research and its impact on hazard classification. Crit Rev Toxicol 31:1–53
  • Holian A, Uthman MO, Goltsova T, Brown SD, Hamilton RF, Jr (1997). Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ Health Perspect 105:1139–42
  • Hurbánková M, Tilkes F. (1993). Use of the test for estimation of LDH activity as one parameter for demonstrating cytotoxicity of fibrous dust. Pracov Lék 45:149–53
  • Hurbánková M, Kaiglová A. (1997). Some bronchoalveolar lavage parameters and leukocyte cytokine release in response to intratracheal instillation of short and long asbestos and wollastonite fibres in rats. Physiol Res 46:459–66
  • Hurbánková M, Kaiglová A. (1999). Compared effects of asbestos and wollastonite fibrous dusts on various biological parameters measured in bronchoalveolar lavage fluid. J Trace Microprobe Tech 17:233–43
  • Hurbánková M, Kaiglová A, Gergelová P, Wsólová L. (2004). Acute and subchronic effects of short and long asbestos and wollastonite fibres in the lung of rats. Cent Eur J Occup Environ Med 10:127–38
  • Huuskonen M, Tossavainen A, Koskinen H, et al. (1982). Respiratory morbidity of quarry workers exposed to wollastonite (Abstract). In: Proceedings of the International Conference on Occupational Lung Diseases, 24–27 March 1982. Chicago, IL. Park Ridge, IL: American College of Chest Physicians
  • Huuskonen M, Tossavainen A, Koskinen H, et al. (1983a). Wollastonite exposure and lung fibrosis. Environ Res 30:291–304
  • Huuskonen M, Jarvisalo J, Koskinen H, et al. (1983b). Preliminary results from a cohort of workers exposed to wollastonite in a Finnish limestone quarry. Scand J Work Environ Health 9:169–75
  • Huuskonen M, Tossavainen A. (1996). Health effects associated with wollastonite exposure. J Occup Health Safety Aust NZ 12:357–60
  • Indian Minerals Yearbook. (2012). Wollastonite (Advance Release). Indian Minerals Yearbook, 2011 (Part II), 50th edition, October, 2012. Nagpur, India: Government of India, Ministry of Mines, Indian Bureau of Mines, pp. 79-2–5
  • International Agency for Research on Cancer (IARC). (1997). IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 68: Silica, some silicates, coal dust and para-aramid fibrils. Lyon, France: International Agency for Research on Cancer, 506 pp
  • International Agency for Research on Cancer (IARC). (1999). Mechanisms of fibre carcinogenesis. In: Kane AB, Boffetta P, Saracci R, Wilbourn JD. (eds.) IARC Scientific Publications No. 140. Geneva: World Health Organization, International Agency for Research on Cancer. [Online] Available at: http://monographs.iarc.fr/ENG/Publications/pub140/IARCpub140.pdf. [Last accessed: 18 Nov 2013]
  • International Life Sciences Institute (ILSI) Working Group. (2005). Testing of fibrous particles: short-term assays and strategies. Report of an ILSI Risk Science Institute Working Group Inhal Toxicol 17:497–537
  • Jianjun D, Ping L, Faqin D. (2003). Experimental study on the in vitro cytotoxicity and its prevention of fibrous mineral dusts. West China Med J 18:374–5
  • Kaifi FMZ, Aurangzeb M, Ahmed B, Khan M. (2004). Manufacture of synthetic wollastonite. J Chem Soc Pak 26:1–4
  • Kansal I, Tulyaganov DU, Goel A, et al. (2010). Structural analysis and thermal behavior of diopside-fluorapatite-wollastonite-based glasses and glass-ceramics. Acta Biomater 6:4380–8
  • Karadagli F. (2011). Comparative assessment of asbestos-containing and alternative materials in Turkish industrial facilities. Indoor Built Environ 20:471–8
  • Karimi A, Taghiyari HR, Fattahi A, et al. (2013). Effects of wollastonite nanofibers on biological durability of poplar wood (Populus nigra) against Trametes versicolor. Bioresources 8:4134–41
  • Keeling B, Hobson J, Churg A. (1993). Effects of cigarette smoke on epithelial uptake of non-asbestos mineral particles in tracheal organ culture. Am J Respir Cell Mol Biol 9:335–40
  • Klockars M, Hedenborg M, Vanhala E. (1990). Effect of two particle surface-modifying agents, polyvinylpyridine-N-oxide and carboxymethylcellulose, on the quartz and asbestos mineral fiber-induced production of reactive oxygen metamolites by human polymorphonuclear leukocytes. Arch Environ Health 45:8–14
  • Kobayashi M, Nakamura T, Okada Y, et al. (1998). Bioactive bone cement: comparison of apatite and wollastonite containing glass ceramic hydroxyapatite and beta-tricalcium phosphate fillers on bone-bonding strength. J Biomed Mater Res 42:223–37
  • Koskinen HO, Nordman HL, Zitting AJ, et al. (1997). Fibrosis of the lung and pleura and long-term exposure to wollastonite. Scand J Work Environ Health 23:41–7
  • Kováčiková Z, Petrovská H, Tátrai E, Dušinská M. (2004). The effect of fibrous dusts on lung cells, in vitro study. Cent Eur J Publ Health 12:S44–8
  • Kyrtopoulos S. (2003). The FIBRETOX Project: mechanisms of toxicity of asbestos substitute mineral fibres: new approaches to hazard and risk assessment. [Online] Available at: http://ec.europa.eu/research/environment/pdf/env_health_projects/chemicals/c-fibretox.pdf. [Last accessed: 18 Nov 2013]
  • Leanderson P, Tagesson C. (1992). Hydrogen peroxide release and hydroxyl radical formation in mixtures containing mineral fibres and human neutrophils. Br J Ind Med 49:745–9
  • Liu J, Liang S, Li S, et al. (1993). Studies on the transforming effects of wollastonite on SHE cells. Acta Acad Med Sin 15:132–7. [in Chinese]
  • Liu W, Ernst JD, Broaddus VC. (2000). Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol 23:371–8
  • Liu X, Hurt RH, Kane AB. (2010). Biodurability of single-walled carbon nanotubes depends on surface functionalization. Carbon 48:1961–9
  • Lockey JE. (1996). Man-made fibers and nonasbestos fibrous silicates. In: Harber P, Schenker M, Balmes J. (eds.) Occupational and environmental respiratory disease. St. Louis, MO: Mosby, 330--44
  • Macdonald JL, Kane AB. (1997). Mesothelial cell proliferation and biopersistence of wollastonite and crocidolite asbestos fibers. Fund Appl Toxicol 38:173–83
  • MAK. (2001). Wollastonite [MAK Value Documentation, 2001]. Wiley Online Library. 19 p. [Online] Available at: http://onlinelibrary.wiley.com/doi/10.1002/3527600418.mb1398317e0016/pdf. [Last accessed: 18 Nov 2013]
  • Marchi E, Liu W, Broaddus VC. (2000). Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution. Am J Physiol Lung Cell Mol Physiol 278:L528–35
  • Mast RW, Maxim LD, Utell MJ, Walker AM. (2000). Refractory ceramic fiber: toxicology, epidemiology, and risk analyses – a review. Inhal Toxicol 12:359–99
  • Maxim LD, McConnell EE. (2005). A review of the toxicology and epidemiology of wollastonite. Inhal Toxicol 17:451–66
  • Maxim LD, Hadley JG, Potter RM, Niebo R. (2006). The role of fiber durability/biopersistence of silica-based synthetic vitreous fibers and their influence on toxicology. Reg Toxicol Pharm 56:42–62
  • Maxim LD, Niebo R, LaRosa S, et al. (2008). Product stewardship in wollastonite production. Inhal Toxicol 20:1199–214
  • Mazzotti M, Abanades JC, Allam R, et al (2005). Chapter 7. Mineral carbonation and industrial uses of carbon dioxide. In: Metz B, Davidson O, de Coninck HC, Loos M, Meyer LA. (eds.) Carbon Dioxide and Storage. Intergovernmental Panel on Climate Change (IPCC). Cambridge, UK: Cambridge University Press, 431 pp. [Online] Available at: http://www.ipcc-wg3.de/special-reports/special-report-on-carbon-dioxide-capture-and-storage. [Last accessed: 18 Nov 2013]
  • McConnell EE, Hall L, Adkins B. (1991). Studies on the chronic toxicity (inhalation) of wollastonite in Fischer 344 rats. Inhal Toxicol 3:323–37
  • McConnell EE. (1995). Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz. Occup Environ Med 52:621
  • Merchant JA. (1990). Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease. Environ Health Perspect 88:287–93
  • Minarelli-Gaspar AM, Saska S, da Cunha LR, et al. (2008). Comparison of the biological behavior of wollastonite bioceramics prepared from synthetic and natural precursors. Key Eng Mater 361:1083–6
  • Monshi A, Salehi K, Nourbakhsh A. (2009). The study of synthetic wollastonite from the CaCO3 stone wastes. Majlesi J Mater Eng 3:1--10 . Available at: http://ma.majlesi.info/index/index.php/material/article/view/89. [Last accessed: 18 Nov 2013].
  • Muhle H, Bellmann B, Pott F. (1991). Durability of various mineral fibers in rat lungs. In: Brown RC, Hoskins JA, Johnson NF. (eds.) Mechanisms in fiber carcinogenesis. New York, NY: Plenum Press, 181–7
  • Muhle H, Bellmann B, Pott F. (1994). Comparative investigations of the biodurability of mineral fibers in the rat lung. Environ Health Perspect 102:163–8
  • National Institute for Occupational Safety and Health (NIOSH). (2002). Health Effects of Occupational exposure to respirable crystalline silica. Department of Health and Human Services, Centers for Disease Control Prevention. Atlanta, Georgia: National Institute for Occupational Safety and Health, 145 pp
  • National Institute for Occupational Safety and Health (NIOSH). (2006). Criteria for a recommended standard occupational exposure to refractory ceramic fibers. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control Prevention, National Institute for Occupational Safety and Health. [Online] Available at: www.cdc.gov/niosh/docs/2006-123/pdfs/2006-123.pdf. [Last accessed: 18 Nov 2013]
  • National Research Council (NRC). (2000). Review of the U.S. Navy’s Exposure Standard for Manufactured Vitreous Fibers. Subcommittee on Manufactured Vitreous Fibers, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences National Research Council. Washington, DC: National Academy Press. [Online] Available at: http://www.nap.edu/catalog.php?record_id=9867 [Last accessed: 18 Nov 2013]
  • Nejjari A, Foumier J, Pezerat H, Leanderson P. (1993). Mineral fibres: correlation between oxidising surface activity and DNA base hydroxylation. Br J Ind Med 50:501–4
  • Nizami MS. (1993). Studies on the synthesis of wollastonite from rice husk ash and limestone. Thesis, Institute of Chemistry, University of the Punjab, Lahore, 280 pp. [Online] Available at: http://eprints.hec.gov.pk/1534/1/1416.HTM. [Last accessed: 18 Nov 2013]
  • Noonan CW, Pfau JC, Larson TC, Spence MR. (2006). Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 141:1243–7
  • Nyberg P, Klockars M. (1990). Measurement of reactive oxygen metabolites produced by human monocyte-derived macrophages exposed to mineral dusts. Int J Exp Pathol 71:537–44
  • NYSERDA. (2012). Disposing of greenhouse gases through mineralization using the wollastonite deposits of New York State. New York: New York State Energy Research and Development Authority (NYSDERA), 2 pp. [Online] Available at: http://www.nyserda.ny.gov/Publications/Research-and-Development-Technical-Reports/Environmental-Reports/EMEP-Publications/-/media/Files/Publications/Research/Environmental/EMEP/10114_project_update.ashx. [Last accessed: 18 Nov 2013]
  • Oberdörster G. (2000). Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health 73:S60–8
  • Ohsawa K, Neo M, Okamoto T, et al. (2004). In vivo absorption of porous apatite- and wollastonite-containing glass-ceramic. J Mater Sci Mater Med 15:859–64
  • Okada Y, Kobayashi M, Neo M, et al. (2001). Ultrastructure of the interface between bioactive composite and bone: comparison of apatite and wollastonite containing glass ceramic filler with hydroxyapatite and beta-tricalcium phosphate fillers. J Biomed Mater Res 57:101–7
  • Ortega-Lara W, Cortes-Hernandez DA, Best S, et al. (2010). Antibacterial properties, in vitro bioactivity and cell proliferation of titania–wollastonite composites. Ceram Int 36:513–9
  • Pailes WH, Judy DJ, Resnick H, Castranova V. (1984). Relative effects of asbestos and wollastonite on alveolar macrophages. J Toxicol Environ Health 14:497–510
  • Pereira HS, Korndorfer GH, de Aquino Vidal A, Sartori de Camargo M. (2004). Silicon sources for rice crop. Sci Agric (Piracicaba, Braz.) 61:522–8
  • Perkins RC, Broaddus VC, Shetty S, et al. (1999). Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am J Respir Cell Mol Biol 21:637–46
  • Peters SC, Blum JD, Driscoll CT, Likens GE. (2004). Dissolution of wollastonite during the experimental manipulation of Hubbard Brook Watershed 1. Biogeochemistry 67:309–29
  • Pfau JC, Sentissi JJ, Li S, et al. (2008). Asbestos-induced autoimmunity in C57Bl/6 mice. J Immunotoxicol 5:129–37
  • Pfau JC, Seib T, Overodker JJ, et al. (2012). Functional expression of system Xc- is upregulated by asbestos but not crystalline silica in murine macrophages. Inhal Toxicol 24:476–85
  • Pietruska JR, Johnston T, Zhitkovich A, Kane AB. (2010). XRCC1 Deficiency sensitizes human lung epithelial cells to genotoxicity by crocidolite asbestos and Libby amphibole. Environ Health Perspect 118:1707–13
  • Potter RM. (2004). Owens-Corning Corp, Personal Communication, November 19, 2004
  • Rodrigues FA, Datnoff LE. (2005). Silicon and rice disease management. Fitopatologia Brasileira 30:457–69
  • Rodriguez-Lorenzo LM, Carrodeguas RG, Rodríguez MA, et al. (2007). Development of wollastonite-poly(ethylmethacrylate co-vinylpyrrolidone) based materials for multifunctional devices. J Biomed Mater Res A 81:603–10
  • Rodriguez-Lorenzo LM, Garcia-Carrodeguas R, Rodriguez MA, et al. (2009). Synthesis, characterization, bioactivity and biocompatibility of nanostructured materials based on the wollastonite-poly(ethylmethacrylate-co-vinylpyrrolidone) system. J Biomed Mater Res A 88:53–64
  • Rosenthal GJ, Germolec DR, Blazka ME, et al. (1994). Asbestos stimulates IL-8 production from human lung epithelial cells. Immunology 153:3237–44
  • Sanchez VC, Pietruska JR, Miselis NR, et al. (2009). Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdisip Rev Nanomed Nanobiotechnol 1:511–29
  • Schneider T, Skotte J. (1990). Fiber exposure reassessed with the new indices. Environ Res 51:108–16
  • Segrave AM, Parikh K, Lowe T, et al. (2013). Materials characterization of ore deposit: Is it Asbestos? Paper presented at the 2013 American Society for Testing and Materials (ASTM) – International Michael E. Beard Conference, Jacksonville, FL, January 31–February 01, 2013, 25 slides
  • Shasby DM, Petersen M, Hodous T, et al. (1979). Respiratory morbidity of workers exposed to wollastonite through mining and milling. In: Lemen R, Dement JM. (eds.) Dusts and disease: occupational and environmental exposures to selected fibrous and particulate dust. Park Forest South, IL: Pathotox Publishers, 251–6
  • Shue L, Yueng Z, Mony U. (2012). Biomaterials for periodontal regeneration. A review of ceramics and polymers. Biomaterials 2:271–7
  • Skaug V, Davies R, Gylseth B. (1984). In vitro macrophage cytotoxicity of five calcium silicates. Br J Ind Med 41:116–21
  • Sponer P, Urban K, Kucera T. (2011). Chapter 21. Comparison of apatite-wollastonite glass-ceramic and β-tricalcium phosphate used as bone graft substitutes after curettage of bone cysts. In: Costas Sikalidis, editor. Advances in ceramics – electric and magnetic ceramics, bioceramics, ceramics and environment. New York: InTech, 473--84
  • Stanton MF, Wrench C. (1972). Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 48:797–821
  • Stanton MF, Layard M, Tegeris A, et al. (1981). Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67:965–5
  • Tátrai E, Kováçiková Z, Brózik M, Six Ė. (2004). Pulmonary toxicity of wollastonite in vivo and in vitro. J Appl Toxicol 24:147–54
  • Tátrai E, Brózik M, Kováciková Z. (2006). Redox status and expression of chemokines in the rat lungs on exposure to asbestos and asbestos substituents. Neurol Endocrinol Lett 27:40–3
  • Teramoto H, Kawaii A, Shinsuke S, et al. (2005). Resorption of apatite-wollastonite containing glass-ceramic and beta-tricalcium phosphate in vivo. Acta Medica Okayama 59:201–7
  • United National Environment Programme (UNEP). (2008). Report of the World Health Organization workshop on mechanisms of fibre carcinogenesis and assessment of chrysotile asbestos substitutes. November 8–12 2005. Lyon France: UNEP/FAO/RC/COP.4/1, 139 p. [Online] Available at: http://www.who.int/ipcs/assessment/public_health/asbestos_substitutes.pdf. [Last accessed: 18 Nov 2013]
  • Utell M. (2010). Respiratory health surveillance in NYCO workers, 2008. Willsboro, NY: NYCO
  • Vaslet CA, Messier NJ, Kane AB. (2002). Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice. Toxicol Sci 68:331–8
  • Virta RL, Van Gosen BS. (2001). Industrial minerals of the United States. Wollastonite – a versatile industrial mineral. USGS Fact Sheet FS-002-01. [Online] Available at: http://pubs.usgs.gov/fs/fs-0002-01/fs-0002-01.pdf. [Last accessed: 18 Nov 2013]
  • Virta RL. (2011). Wollastonite. U.S. Geological Survey, Mineral Commodity Summaries, January, 2011. Washington, DC: USGS, p 182–3
  • Virta RL. (2013). Wollastonite [Advance Release]. 2012 Minerals Yearbook, U.S. Department of the Interior. Washington DC: U.S. Geological Survey, 3 p. [Online] Available at: http://minerals.usgs.gov/minerals/pubs/commodity/wollastonite/myb1-2012-wolla.pdf. [Last accessed: 18 Nov 2013]
  • Warheit DB, Hartsky MA, McHugh TA, Kellar KA. (1994a). Biopersistence of inhaled organic and inorganic fibers in the lungs of rats. Environ Health Perspect 102:151–7
  • Warheit DB, McHugh TA, Kellar KA, Hartsky MA. (1994b). Biopersistence and pulmonary effects of inhaled p-aramid or wollastonite fibers following short-term exposures, In: Dungworth DL, Mauderly JL, Oberdörster G. (eds.) Carcinogenic effects of solid particles in the respiratory tract. Washington, DC: ILSI Press
  • Warheit DB, Reed KL, Webb TR. (2001). Man-made respirable-sized organic fibers: what do we know about their toxicological profiles?. Ind Health 39:119–25
  • Woźniak H, Wiecek E, Tossavainen A, et al. (1986). Comparative studies of fibrogenic properties of wollastonite, chrysotile and crocidolite. Med Pr 37:288–96
  • Zeiger E, Anderson B, Haworth S, et al. (1987). Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen Suppl S9:1–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.